Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
topic_facet:"Recruitment Status: Authorised-recruitment may be ongoing or finished"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&lookfor=%22Myeloma%22&type=Subject
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&lookfor=%22Myeloma%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&lookfor=%22Myeloma%22&type=Subject
PubPharm (1.376)
1
A study to compare the efficacy and safety of bb2121 to standard treatment in people who have Myeloma that is not responsive after treatment or who had Myeloma which has returned after a period of treatment. : A Phase 3, Multicenter, Randomized, Open Label Study to Compare the Efficacy and Safety of BB2121 Versus Standard Triplet Regimens in Subjects with Relapsed and Refractory Multiple Myeloma (Rrmm) (KarMMa-3)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
An Open Label Study of JNJ-68284528, Directed Against BCMA in Subjects with Multiple Myeloma : A Phase 2, Multicohort Open-Label Study of JNJ-68284528, a Chimeric Antigen Receptor T cell (CAR-T) Therapy Directed Against BCMA in Subjects with Multiple Myeloma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A study to compare the efficacy and safety of bb2121 to standard treatment in people who have Myeloma that is not responsive after treatment or who had Myeloma which has returned after a period of treatment. : A Phase 3, Multicenter, Randomized, Open Label Study to Compare the Efficacy and Safety of BB2121 Versus Standard Triplet Regimens in Subjects with Relapsed and Refractory Multiple Myeloma (Rrmm) (KarMMa-3)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
An Open Label Study of JNJ-68284528, Directed Against BCMA in Subjects with Multiple Myeloma : A Phase 2, Multicohort Open-Label Study of JNJ-68284528, a Chimeric Antigen Receptor T cell (CAR-T) Therapy Directed Against BCMA in Subjects with Multiple Myeloma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants with Previously Untreated Multiple Myeloma : A Phase 3, Randomized, Controlled, Open-label Study of VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Combination with VMP (D-VMP), in Subjectswith Previously Untreated Multiple Myeloma who are Ineligible for High-dose Therapy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A Study of combination of Daratumumab, VELCADE (bortezomib), Lenalidomide, and Dexamethasone (D-VRd) compared to VELCADE, Lenalidomide, and Dexamethasone (VRd) in participants with Previously Untreated Multiple Myeloma : A Phase 3 Study Comparing Daratumumab, VELCADE (bortezomib), Lenalidomide, and Dexamethasone (D-VRd) vs VELCADE, Lenalidomide, and Dexamethasone (VRd) in Subjects with Previously Untreated Multiple Myeloma who are Eligible for High-dose Therapy - The Perseus trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants with Previously Untreated Multiple Myeloma : A Phase 3 Study Comparing Daratumumab, Lenalidomide, and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects with Previously Untreated Multiple Myeloma who are Ineligible for High Dose Therapy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Phase III study of belantamab mafodotin, bortezomib, and dexamethasone (B-Vd) versus daratumumab, bortezomib, and dexamethasone (D-Vd) in participants with relapsed/refractory multiple myeloma : DREAMM 7: A Multicenter, Open-Label, Randomized Phase III Study to Evaluate the Efficacy and Safety of the Combination of Belantamab Mafodotin, Bortezomib, and Dexamethasone (B-Vd) Compared with the Combination of Daratumumab, Bortezomib and Dexamethasone (D-Vd) in Participants with Relapsed/Refractory Multiple Myeloma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A Study to Evaluate the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen-Exposed Patients with Relapsed/Refractory Multiple Myeloma : A PHASE I/II, OPEN-LABEL, MULTI-COHORT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CEVOSTAMAB IN PRIOR B CELLMATURATION ANTIGEN-EXPOSED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants with Previously Untreated Multiple Myeloma : A Phase 3, Randomized, Controlled, Open-label Study of VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Combination with VMP (D-VMP), in Subjectswith Previously Untreated Multiple Myeloma who are Ineligible for High-dose Therapy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[138]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Recruitment Status: Authorised-recruitment may be ongoing or finished
Medienart
1.376
Aufsätze
1.376
E-Artikel
1.376
E-Ressourcen
Zeitschriftentitel
1.376
WHO International Clinical Trials Registry Plat...
Thema
1.376
610
Recruitment Status: Authorised-recruitment may ...
1.376
Study Type: Interventional
656
Phase: Phase 3
334
Phase: Phase 2
152
Medical Condition: Multiple Myeloma MedDRA vers...
138
Phase: Phase 1
64
Medical Condition: Multiple myeloma MedDRA vers...
60
Medical Condition: Relapsed/Refractory Multiple...
46
Phase: Phase 4
36
Medical Condition: MULTIPLE MYELOMA MedDRA vers...
36
Medical Condition: Relapsed or Refractory Multi...
24
Medical Condition: Plasma cell myeloma MedDRA v...
24
Medical Condition: Relapsed or Refractory Multi...
24
Medical Condition: Smoldering Multiple Myeloma ...
20
Medical Condition: Patients with Relapsed Refra...
18
Medical Condition: Newly diagnosed multiple mye...
18
Medical Condition: Relapsed or Refractory Multi...
18
Medical Condition: Smoldering multiple myeloma ...
16
Medical Condition: Relapsed and lenalidomide-re...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
906
2020-
470
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.332
Englisch
28
Unbestimmt
8
Französisch
4
Dänisch
2
Galizisch
2
Spanisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...